Who owns the SYFOVRE trademark?

The SYFOVRE trademark is owned by Apellis Pharmaceuticals, Inc..

What class is the SYFOVRE trademark registered in?

The SYFOVRE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for SYFOVRE?

The USPTO serial number for SYFOVRE is 90852938.

What is the registration number for SYFOVRE?

SYFOVRE is registered under USPTO registration number 7049997.

Sealvo

Home Search: SYFOVRESYFOVRE #90852938

Back

Updated Oct 19, 2026·20 searches this week

View on USPTO TSDR Find similar marks

SYF

USPTO Trademark Record

REGISTERED

SYFOVRE

SN 90852938·Reg 7049997·Filed Jul 28, 2021

Owner Apellis Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

SYFOVRE (Serial No. 90852938), Registration No. 7049997, is a registered US trademark filed on Jul 28, 2021 by Apellis Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: May 09, 2029

Mark Intelligence

SYFOVRE (Reg. #7049997) is a registered US trademark that has been protecting its owner, Apellis Pharmaceuticals, Inc., since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 28, 2021

SERIAL

90852938

REG#

7049997

REGISTERED

May 09, 2023

Filing Information

StatusREGISTERED

Filing DateJul 28, 2021

Serial Number90852938

Registration No.7049997

Registration DateMay 09, 2023

Status DateMay 09, 2023

Published for OppositionMay 31, 2022

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1646426

480Jan 20, 2022

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Mar 01, 2023

First use in commerce: Mar 01, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

20 events

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Aug 12, 2026

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 09, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

REGISTERED-PRINCIPAL REGISTER

May 09, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 07, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Apr 06, 2023

STATEMENT OF USE PROCESSING COMPLETE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 06, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 05, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Mar 20, 2023

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Mar 20, 2023

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 29, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

NEW NOA TO ISSUE

Oct 17, 2022

NEW NOA TO ISSUE

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 28, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

NOTICE OF ALLOWANCE CANCELLED

Jul 26, 2022

NOTICE OF ALLOWANCE CANCELLED

PUBLISHED FOR OPPOSITION

May 31, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 31, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 11, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 26, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Apr 25, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 25, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 31, 2021

NEW APPLICATION ENTERED

Other Marks by Apellis Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

APE

APELLIS

90505497

Apellis Pharmaceuticals, Inc.

REGISTERED

GAL

G.A.LLERY

98221674

Apellis Pharmaceuticals, Inc.

REGISTERED

EMP

EMPAVELI

97460836

Apellis Pharmaceuticals, Inc.

REGISTERED

LOG

LogoMark

97460833

Apellis Pharmaceuticals, Inc.

REGISTERED

Other Marks by John V. Hobgood, Esquire

Additional USPTO filings handled by the same attorney of record.

BUI

BUILD UP JUSTICE

99000410

REGISTERED

THE

THE BOONLY

97448369

REGISTERED

MEE

MEETING OWL

87232927

REGISTERED

OWL

OWL LABS

87232911

REGISTERED

SYFOVRE

Run a conflict check

Other Marks by Apellis Pharmaceuticals, Inc.

Other Marks by John V. Hobgood, Esquire

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company